Abstract:Objective To investigate the clinical experiences and short-term therapeutic effects of laparoscopic radical prostatectomy (LRP) for high-risk and local advanced prostate cancer after a three-month neo-adjuvant endocrine therapy. Methods With age ranging from 55 to 81, all patients were screened by ultrasound guided 12 cores prostate biopsy, among which 79 cases were diagnosed as prostate cancer. According to the prostate specific antigen (PSA) in blood before operation, Gleason scores and magnetic resonance imaging (MRI), 36 cases were diagnosed as localized prostate cancer (group A), and 43 cases were diagnosed as high-risk and local advanced prostate cancer (group B). Group A was subjected to LRP four to six weeks after biopsy, while group B received three-month neo-adjuvant endocrine therapy (maximal androgen blockade) and LRP in sequence. Results The PSA of group A was 3.6-15.8 ng/ml (mean: 9.3 ng/ml). After three-month neo-adjuvant endocrine therapy, PSA of group B reduced from 12.6-45.2 ng/ml (mean:23.6 ng/ml) before biopsy to 0.02-3.6 ng/ml (mean:1.2 ng/ml). The operation time of group A was 65-180 minutes (mean:136 minutes), and that of group B was 70 to 120 minutes (mean:152 minutes). The intraoperative blood loss of group A was 30-400 ml without blood infusion, while that of group B was 50-600 ml, with 2 patients received red blood cells infusion of 400 ml. No severe complications occurred in both groups, such as rectal injuries, peripheral organs injuries and so on. Postoperative pathology found 2 positive surgical margins in group A, without positive case in bladder neck, seminal vesicle and regional lymph nodes. Group B was found 6 positive cases in prostate resection margin, bladder neck and seminal vesicle, and 4 positive regional lymph nodes. One month after LRP, PSA of group A and group B were 0.001-0.03 ng/ml and 0.01-0.45 ng/ml, respectively. Patients with positive pathologic results in prostate resection margin, bladder neck, seminal vesicle and regional lymph nodes received adjuvant endocrine therapy immediately, as well as those with biochemical recurrence in the follow-ups. After a follow-up duration of 6 to 20 months, 3 cases were found with biochemical recurrence, one case with regional recurrence in group A, without bone metastasis and distant metastasis. In group B, 12 cases were found with biochemical recurrence, 4 cases with regional recurrence and 2 cases with bone metastasis and distant metastasis. Conclusion Neo-adjuvant endocrine therapy can reduce the volume of prostate cancer significantly, allow high-risk and local advanced patients to operation by reducing clinical stage, without increasing operative difficulty and complications obviously, compared to localized prostate cancer. Neo-adjuvant endocrine therapy in combination with LRP provides a new therapeutic approach for patients with high risk and local advanced prostate cancer. However, relative high rates of cancer recurrence and metastasis still exist. Compared with traditional hormone therapy, whether this approach can improve long-term prognosis of patients with prostate cancer still awaits investigation into the results of long-term follow-ups.

Long-term efficacy of one-shot intra-arterial chemotherapy before radical cystectomy

The Long-Term Efficacy of One-Shot Neoadjuvant Intra-Arterial Chemotherapy Combined with Radical Cystectomy Versus Radical Cystectomy Alone for Bladder Cancer: a Propensity-Score Matching Study

Survival after Radical Cystectomy for Bladder Cancer: Multicenter Comparison Between Minimally Invasive and Open Approaches

Clinical Outcomes of Pelvic Lymph Node Dissection Before Versus after Robot-Assisted Laparoscopic Radical Cystectomy

Singe intraoperative instillation of chemotherapy during radical cystectomy for bladder cancer: Oncological outcome and survival predictors

Single-dose intra-arterial infusion chemotherapy for refractory bladder cancer after transurethral resection of bladder tumor: Report of 12 cases

Long-term oncologic outcomes and complications of robot-assisted radical cystectomy for the treatment of urothelial carcinoma of the bladder

Clinical Outcome of Laparoscopic Versus Robot-Assisted Radical Cystectomy for Patients with Bladder Cancer: a Retrospective Study

Efficacy of short-course radiotherapy concurrent with chemotherapy and delayed surgery for high-risk locally advanced rectal adenocarcinoma

Clinical Significance of Radical Cystectomy with Extended Lymphadenectomy

Intra-Arterial Chemotherapy for Muscle-Invasive Bladder Cancer Following Transurethral Resection

[Compare of Laparoscopic and Open Surgery for Radical Cystectomy with Orthotopic Ileal Neobladder].

Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis

Efficacy of Laparoscopic Radical Resection Combined with Neoadjuvant Chemotherapy and Its Impact on Long-Term Prognosis of Patients with Colorectal Cancer

Single institutional experience of neoadjuvant therapy prior to planned surgical resection for complex or locoregional renal cell carcinoma.

Follow-up of 127 cases after laparoscopic radical nephrectomy

A Prospective Randomised Controlled Trial of Laparoscopic Vs Open Radical Cystectomy for Bladder Cancer: Perioperative and Oncologic Outcomes with 5-Year Follow-Upt Lin Et Al

A prospective comparison of intra-arterial chemotherapy combined with intravesical chemotherapy and intravesical chemotherapy alone after transurethral resection with a thulium laser in high-risk non-muscle invasive bladder cancer

Clinical experience of laparoscopic radical prostatectomy in high-risk and local advanced prostate cancer after neoadjuvant therapy

Intra-Arterial Infusion Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Preliminary Experience on the Safety, Efficacy, and Clinical Outcomes

Preoperative Selective Internal Iliac Arterial Chemotherapy for Invasive Bladder Cancer